(4R,4'R,5S,5'S)-2,2'-cyclopropylidenebis[4,5-dihydro-4,5-diphenyl-Oxazole
|
|
(4R,4'R,5S,5'S)-2,2'-cyclopropylidenebis[4,5-dihydro-4,5-diphenyl-Oxazole Eigenschaften
- Schmelzpunkt:
- 163-165 °C
- Siedepunkt:
- 620.8±55.0 °C(Predicted)
- Dichte
- 1.23±0.1 g/cm3(Predicted)
- storage temp.
- under inert gas (nitrogen or Argon) at 2–8 °C
- pka
- 4.66±0.70(Predicted)
Sicherheit
(4R,4'R,5S,5'S)-2,2'-cyclopropylidenebis[4,5-dihydro-4,5-diphenyl-Oxazole Chemische Eigenschaften,Einsatz,Produktion Methoden
(4R,4'R,5S,5'S)-2,2'-cyclopropylidenebis[4,5-dihydro-4,5-diphenyl-Oxazole Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(4R,4'R,5S,5'S)-2,2'-cyclopropylidenebis[4,5-dihydro-4,5-diphenyl-Oxazole Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 24)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Shanghai Daken Advanced Materials Co.,Ltd | +86-371-66670886 |
info@dakenam.com | China | 18751 | 58 |
Shanghai Acmec Biochemical Technology Co., Ltd. | +undefined18621343501 |
product@acmec-e.com | China | 33338 | 58 |
Aladdin Scientific | +1-+1(833)-552-7181 |
sales@aladdinsci.com | United States | 57505 | 58 |
SHANGHAI KEAN TECHNOLOGY CO., LTD. | +8613817748580 |
cooperation@kean-chem.com | China | 40066 | 58 |
Taizhou Nanfeng Pharmaceutical Research Institute | 18616377689 |
nanfengdrug@163.com | China | 20000 | 58 |
Daicel Chiral Technologies (China)CO.,LTD | 021-50460086-9 15921403865 |
han_yajun@dctc.daicel.com | China | 7195 | 65 |
Tianjin Derchemist Science & Technology Co., Ltd. | 22-58627059 13920586291 |
zdcomcon@126.com | China | 3461 | 50 |
Bide Pharmatech Ltd. | 400-164-7117 13681763483 |
product02@bidepharm.com | China | 41462 | 60 |
Shanghai Chiral bio-compound co., Ltd. | 021-5068 3667/17749785980/1029026415; 17749785980 |
1029026415@qq.com | China | 3013 | 58 |
Greenherbs Science and Technology Development Co., Ltd. | 010-61136123 |
pub02@greenherbs.com.cn | China | 4049 | 58 |
- (4R,4'R,5S,5'S)-2,2'-cyclopropylidenebis[4,5-dihydro-4,5-diphenyl-Oxazole
- (4R,4'R,5S,5'S)-2,2'-Cyclopropylidenebis[4,5-dihydro-4,5- diphenyloxazole],99%e.e.
- (4R,4'R,5S,5'S)-2,2'-Cyclopropylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%, (99% ee)
- Oxazole, 2,2'-cyclopropylidenebis[4,5-dihydro-4,5-diphenyl-, (4R,4'R,5S,5'S)- (9CI)
- (4R,4'R,5S,5'S)-2,2'-(Cyclopropane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)
- Oxazole, 2,2'-cyclopropylidenebis[4,5-dihydro-4,5-diphenyl-,(4R,4'R,5S,5'S)-
- (4R,4'R,5S,5'S)-2,2'-cyclopropylidenebis[4,5-dihydro-4,5-diphenyl-Oxazole
- (4R,4''R,5S,5''S)-2,2''-Cyclopropylidenebis[4,5-dihydro-4,5-diphenyloxazole]
- (4R,4'R,5S,5'S)-2,2'-(Cyclopropane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)
- 229184-96-7
- C33H28N2O2